NonalcoholicSteatohepatitis相关论文
Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephro
Disease-mediated alterations to drug disposition constitute a significant source of adverse drug reactions.Cisplatin(CDD......
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is currently the most common chronic liver disease and af......
Effect of Total Flavone of Haw Leaves on Nuclear Factor Erythroid-2 Related Factor and Other Related
Objective:To investigate the effect of total flavone of haw leaves (TFHL) on the expression of nuclear factor erythroid-......
Decreased accumulation of ultrasound contrast in the liver of nonalcoholic steatohepatitis rat model
...
Persistent disruption of mTORC1 in macrophages leads to enhanced nonalcoholic steatohepatitis in mic
Introduction: Nonalcoholic steatohepatitis(NASH),characterized by lipid deposits within hepatocytes,is associated with h......
...
LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from non
Background: Nonalcoholic fatty liver disease (NAFLD) is one of the main liver diseases, and its pathologic profile inclu......
Background: Nonalcoholic fatty liver disease and its advanced stage, nonalcoholic steatohepatitis (NASH), are the major ......
Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients d
Background: Although concomitant nonalcoholic steatohepatitis (NASH) is common in chronic hepatitis B (CHB), the impact ......
近年来，非酒精性脂肪性肝炎(NASH)的发病率快速上升，已成为主要肝病之一。由于其复杂性和异质性，至今尚无应用于临床的有效治疗药物和......
目前，对于树突状细胞（ DCs）的研究一般集中于骨髓来源的DCs、脾脏 DCs及外周血DCs的形态学和免疫学特性。肝脏是人体内的重要免疫器官......
目的观察异甘草酸镁、多烯磷脂酰胆碱联合瑞舒伐他汀治疗非酒精性脂肪性肝炎的疗效。方法非酒精性脂肪性肝炎72例随机分为治疗组和......
AIM: To evaluate the clinical and biochemical profile of patients with non alcoholic fatty liver disease (NAFLD)and to a......
Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in ra
AIM: To investigate whether increased intestinal permeability contributes to the pathogenesis and progress of nonalcohol......
Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are diffe
TO THE EDITORrnWe read with great interest the article, Non-alcoholic fatty liver disease may not be a severe disease a......
AIM:To investigate the innate immune reactivity of tumor necrosis factor-alpha (TNF-α),Toll-like receptor 4 (TLR4),and ......
磷脂酰乙醇胺N-甲基转移酶(PEMT)能够催化磷脂酰乙醇胺(PE)转化为磷脂酰胆碱(PC),并参与肝细胞内多种代谢反应,与肝脂质代谢、内质......
AIM: To create a rabbit model of pediatric nonalcoholic steatohepatitis (NASH) and to evaluate the role of adiponectin i......
Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: Our case series and literature rev
Recently, nonalcoholic steatohepatitis (NASH) has been considered to be another cause of liver cirrhosis and hepatocellu......
目的:探讨MMP-1,NMP-2,MT1-MMP和MT2-MMP在NASH肝纤维化中的相互作用及可能机制.方法:采用原位分子杂交方法检测40例NASH患者的肝......
Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in the world. The ris......
Worldwide, hepatocellular carcinoma (HCC) is a frequent complication of liver diseases and remains a major cause of canc......
AIM To review the effectiveness of exercise as atherapy for nonalcoholic fatty liver disease （NAFLD）and potential benefits......
Recent advances in mouse models of obesityandnonalcoholic steatohepatitis-associatedhepatocarcinogen
Hepatocellular carcinoma （HCC） is the fifth mostcommon cancer, and obesity has been establishedas a risk factor for HCC de......
With the high prevalence of obesity, diabetes, and otherfeatures of the metabolic syndrome in United States,nonalcoholic......
AIM To examine whether poly-unsaturated fatty acid（PUFA） therapy is beneficial for improving nonalcoholicsteatohepatitis （N......
Nonalcoholic fatty liver disease （NAFLD） is one of themajor causes of chronic liver injury. NAFLD includes awide range of ......
The growing diffusion of nonalcoholic fatty liver disease（NAFLD） is a consequence of the worldwide increasein the prevalen......
Pathophysiological mechanisms involved in non-alcoholicsteatohepatitis and novel potential therapeut
Non-alcoholic fatty liver disease （NAFLD） is a major healthcare problem and represents the hepatic expression ofthe metabo......
Non-alcoholic fatty liver disease （NAFLD） is consideredto be an independent cardiovascular disease （CVD）risk factor. However......
